Promacon SRL
The score of Promacon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +104 % Total assets +74 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Promacon's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 98,629 € | ||||
| Equity | 374,394 € | ||||
| Cash | 75,988 € | ||||
| EBITDA | 141,696 € | ||||
| Total assets | 408,759 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 26 Jan 2026
- Year ended 30 Jun 2024filed on 10 Jan 2025
- Year ended 30 Jun 2023filed on 19 Dec 2023
- Year ended 30 Jun 2022filed on 14 Dec 2022
- Year ended 30 Jun 2021filed on 10 Jan 2022
Promacon's financial analysis
- Solvency91.6%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Promacon
Promacon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0444.408.963
- VAT number
- BE0444408963
- Peppol
- Registered · 0208:0444408963 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jun 1991
- Registered office
- 2540 Hove
- Latest accounts
- 2025 · filed on 26 Jan 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Promacon (SRL) has been based in Hove since 1991, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 98,629 € and equity of 374,394 €; its revenue is not published. Its solvency stands at 91.6%, above the median of its sector (56.0%).
Companies similar to Promacon
Companies in the same business, of comparable size and area, outside its group.
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Montefalcone Projects Manufacture of basic pharmaceutical products Maarkedal · balance sheet 207,746 €
- Asclepia MedChem Solutions Manufacture of basic pharmaceutical products Destelbergen · balance sheet 360,741 €
- Pharma MAR Manufacture of basic pharmaceutical products Brussels · balance sheet 492,662 €
- BelCoPhar Manufacture of pharmaceutical preparations Kalmthout · balance sheet 224,468 €
- DeuterOncology Manufacture of basic pharmaceutical products Liège · balance sheet 688,028 €
- Wandji Pharma International Manufacture of pharmaceutical preparations Tournai · balance sheet 357,118 €
- Bioseutica Belgium Manufacture of basic pharmaceutical products Bastogne · balance sheet 836,552 €
Frequently asked questions about Promacon
What is the revenue of Promacon?
Promacon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Promacon?
In Belgium, the VAT number is the company number prefixed with BE: BE0444408963 for Promacon, if the company is VAT-registered. Its company number (CBE) is 0444.408.963.
Where is the registered office of Promacon?
According to the CBE register, the registered office of Promacon is in 2540 Hove.
What is the equity of Promacon?
At the close of the 2025 financial year, the equity of Promacon amounts to 374,394 €, a solvency of 91.6% of total assets.
Who manages Promacon?
The register lists 1 active mandates at Promacon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Promacon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →